Streetbeat News

Stock Prices

BDRX

Biodexa Pharmaceuticals PLC-ADR (NASDAQ:BDRX) shares plummeted by 31.7% to $2.07 after announcing the pricing of a public offering at significant discounts. The offering includes Class A Units at $2.00 each and Class B Units at $1.9999, both with warrants exercisable at $2.20. The offering is expected to close around December 21, subject to standard conditions.

Portfolio Pulse from Henry Khederian

December 19, 2023 | 2:44 pm

ACN

BCAN

CGEN

ETAO

MOTS

PBLA

ZJYL

U.S. stocks opened higher with the Dow Jones, NASDAQ, and S&P 500 all seeing gains. Materials shares led the market, while financial shares saw a slight decline. Accenture Plc (ACN) reported higher-than-expected Q1 earnings but provided a weaker sales forecast for Q2, expecting revenues to be lower than the consensus. Compugen Ltd. (CGEN), Panbela Therapeutics, Inc. (PBLA), and Jin Medical International Ltd. (ZJYL) saw significant stock price increases. Conversely, Motus GI Holdings, Inc. (MOTS), BYND Cannasoft Enterprises Inc. (BCAN), and ETAO International Co., Ltd. (ETAO) experienced notable declines in their share prices.

Portfolio Pulse from Avi Kapoor

December 19, 2023 | 2:42 pm

SPY

In a recent statement, Federal Reserve Bank of Richmond President Thomas Barkin expressed his view that inflation is more persistent than what the average Federal Reserve official believes. This suggests that the fight against inflation may be more prolonged, potentially influencing the Fed's monetary policy decisions.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 2:41 pm

SPY

Federal Reserve Bank of Richmond President Thomas Barkin stated that he is looking for 'conviction' that inflation is returning to the Fed's target. This comment suggests that the Fed's future policy decisions will be heavily influenced by inflation trends and their alignment with the target rate. Barkin's remarks are indicative of the Fed's ongoing focus on managing inflation without specific details on the measures to be taken.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 2:41 pm

PTCT

Morgan Stanley analyst Jeffrey Hung has downgraded PTC Therapeutics (NASDAQ:PTCT) from Equal-Weight to Underweight and set a price target of $28.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 2:40 pm

AAPL

MSFT

NVDA

QQQ

QQQM

The Nasdaq 100 Index reached a new all-time high of 16,772.71, marking a 53% YTD increase and its best annual performance since the 1999 tech boom. The Invesco QQQ Trust ETF (QQQ) and Invesco NASDAQ 100 ETF (QQQM) also hit new highs. Apple (AAPL), Microsoft (MSFT), and NVIDIA (NVDA) are the top gainers, contributing significantly to the index's returns.

Portfolio Pulse from Surbhi Jain

December 19, 2023 | 2:34 pm

CGEN

Shares of Compugen (CGEN) have been halted due to a circuit breaker triggered by a sharp increase in the stock price, which is now up 217.8%.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 2:34 pm

PRLD

Morgan Stanley analyst Jeffrey Hung has downgraded Prelude Therapeutics (NASDAQ:PRLD) from Equal-Weight to Underweight and reduced the price target from $10 to $4. This reflects a more bearish outlook on the company's stock by the analyst.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 2:33 pm

BTCUSD

ETHUSD

Cryptocurrency prices surged, with Bitcoin (BTC) surpassing $42,000 and Ethereum (ETH) above $2,200. Sei (SEI) led the gains with a 52.5% increase over 24 hours. The global crypto market cap rose to $1.61 trillion, a 4.6% gain. Other notable gainers included WOO Network (WOO), Injective (INJ), Blur (BLUR), VeChain (VET), Immutable (IMX), NEAR Protocol (NEAR), SATS (1000SATS), Helium (HNT), and ORDI (ORDI).

Portfolio Pulse from Avi Kapoor

December 19, 2023 | 2:33 pm

PRSR

Shareholders of Prospector Capital Corp. (PRSR) have voted to approve the business combination with LeddarTech Holdings. The record date for the issuance of one additional Prospector Class A Share for each non-redeemed share will be on the closing date of the transaction.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 2:32 pm